Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3269)
All Articles published online
|
Feb 15, 2003 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Z, Ruan YB, Guan Y, Liu SH. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol 2003; 9(2): 267-270 [PMID: 12532445 DOI: 10.3748/wjg.v9.i2.267] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i2/267.htm |
| Number | Citing Articles |
| 1 |
Michael Höpfner, Alexander Huether, Andreas P. Sutter, Viola Baradari, Detlef Schuppan, Hans Scherübl. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Biochemical Pharmacology 2006; 71(10): 1435 doi: 10.1016/j.bcp.2006.02.006
|
| 2 |
Randa A. Zaghloul, Mamdouh M. El-Shishtawy, Khaled H. Abd El Galil, Mohamed A. Ebrahim, AbdelHamid A. Metwaly, Mohammed M. Al-Gayyar. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma. European Journal of Pharmacology 2015; 746: 353 doi: 10.1016/j.ejphar.2014.11.008
|
| 3 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World Journal of Gastroenterology 2008; 14(1): 1-14 doi: 10.3748/wjg.14.1
|
| 4 |
Mozaffarul Islam, Smita Sharma, Bhavna Kumar, Theodoros N. Teknos. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis. Oral Oncology 2013; 49(8): 778 doi: 10.1016/j.oraloncology.2013.04.003
|
| 5 |
Iliana Fauzi, Nicki Panoskaltsis, Athanasios Mantalaris. Enhanced Hematopoietic Differentiation Toward Erythrocytes from Murine Embryonic Stem Cells with HepG2-Conditioned Medium. Stem Cells and Development 2012; 21(17): 3152 doi: 10.1089/scd.2012.0030
|
| 6 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives. World Journal of Gastroenterology 2008; 14(46): 7021-7032 doi: 10.3748/wjg.14.7021
|
| 7 |
Jian Zhuge, Ye Luo, Ying-Nian Yu. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World Journal of Gastroenterology 2003; 9(12): 2732-2736 doi: 10.3748/wjg.v9.i12.2732
|
| 8 |
Yulin Yuan, Xuhong Zhou, Jian Song, Xiaoping Qiu, Jun Li, Linfeng Ye, Xiaoping Meng, Dong Xia. Expression and Clinical Significance of Epidermal Growth Factor Receptor and Type 1 Insulin-Like Growth Factor Receptor in Nasopharyngeal Carcinoma. Annals of Otology, Rhinology & Laryngology 2008; 117(3): 192 doi: 10.1177/000348940811700306
|
| 9 |
Dan He, Hongpeng Gong, Jie Pan, Fangchao Zhu, Xiaofen Jiang, Huang Su. Recurrent Non-islet Cell Tumor Hypoglycemia Secondary to Hepatocellular Carcinoma: Case Report and Literature Review. Zeitschrift für Gastroenterologie 2024; 62(05): 752 doi: 10.1055/a-2170-1691
|
| 10 |
Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak, Eric Brown, Alexandra Eyzaguirre, Nianjun Tao, Maryland Rosenfeld-Franklin, Lorena Lerner, M. Isabel Chiu, Robert Wild, David Epstein, Jonathan A. Pachter, Mark R. Miglarese. Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer. Molecular Cancer Therapeutics 2010; 9(10): 2652 doi: 10.1158/1535-7163.MCT-10-0318
|
| 11 |
C. Morace, M. Cucunato, R. Bellerone, G. De Caro, S. Crinò, A. Fortiguerra, F. Spadaro, A. Zirilli, A. Alibrandi, P. Consolo, C. Luigiano, M.L. Resta, O. Ferraù, A. Spadaro. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?. European Journal of Internal Medicine 2012; 23(6): e157 doi: 10.1016/j.ejim.2012.04.014
|
| 12 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
|
| 13 |
Qun-sheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, Andrew Cooke, Lixin Feng, Gilda Mak, Matthew O'Connor, Yan Yao, Caroline Pirritt, Elizabeth Buck, Alexandra Eyzaguirre, Lee D. Arnold, Neil W. Gibson, Jonathan A. Pachter. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
. Molecular Cancer Therapeutics 2007; 6(8): 2158 doi: 10.1158/1535-7163.MCT-07-0070
|
| 14 |
Kun-Peng Fang, Jian-Lin Zhang, Yan-Hong Ren, Ye-Ben Qian. Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(6): 2655 doi: 10.7314/APJCP.2014.15.6.2655
|
| 15 |
J. F. Tsai, J. E. Jeng, L. Y. Chuang, H. L. You, L. Y. Wang, M. Y. Hsieh, S. C. Chen, W. L. Chuang, Z. Y. Lin, M. L. Yu, C. Y. Dai. Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2005; 40(1): 68 doi: 10.1080/00365520410009311
|
| 16 |
Mark J. Mulvihill, Elizabeth Buck. Accounts in Drug Discovery. 2010; : 71 doi: 10.1039/9781849731980-00071
|
| 17 |
Daphna Mokady, David Meiri. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance. Drug Resistance Updates 2015; 19: 22 doi: 10.1016/j.drup.2015.01.001
|
| 18 |
Sunita Kumari, Arka De, Naveen Kalra, Virendra Singh. Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial. American Journal of Gastroenterology 2024; 119(1): 116 doi: 10.14309/ajg.0000000000002300
|
| 19 |
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
|
| 20 |
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
|
| 21 |
Miloš Šunderić, Vesna Malenković, Olgica Nedić. Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor. Experimental and Molecular Pathology 2015; 98(2): 173 doi: 10.1016/j.yexmp.2015.03.003
|
| 22 |
|
| 23 |
Seon-Hee Yim, Yeun-Jun Chung. An Overview of Biomarkers and Molecular Signatures in HCC. Cancers 2010; 2(2): 809 doi: 10.3390/cancers2020809
|
| 24 |
Motawa E. El-Houseini, Mohammed S. Mohammed, Wael M. Elshemey, Tarek D. Hussein, Omar S. Desouky, Anwar A. Elsayed. Enhanced Detection of Hepatocellular Carcinoma. Cancer Control 2005; 12(4): 248 doi: 10.1177/107327480501200407
|
| 25 |
Elizabeth Buck, Mark Mulvihill. Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer. Expert Opinion on Investigational Drugs 2011; 20(5): 605 doi: 10.1517/13543784.2011.558501
|
| 26 |
Jennifer Wu, Andrew X Zhu. Targeting insulin-like growth factor axis in hepatocellular carcinoma. Journal of Hematology & Oncology 2011; 4(1) doi: 10.1186/1756-8722-4-30
|
| 27 |
Kimberly Terry, Mehmet Sitki Copur. Molecular Targeted Therapy of Hepatocellular Carcinoma. Journal of Cancer Therapy 2013; 4(02): 426 doi: 10.4236/jct.2013.42A052
|
| 28 |
Stefania Bortoluzzi, Andrea Bisognin, Chiara Romualdi, Gian Antonio Danieli. Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profiling. Gene 2005; 348: 65 doi: 10.1016/j.gene.2004.12.024
|
| 29 |
Li Wang, Min Yao, Zhizhen Dong, Yun Zhang, Dengfu Yao. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumor Biology 2014; 35(1): 9 doi: 10.1007/s13277-013-1141-0
|
| 30 |
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. International Journal of Molecular Sciences 2021; 22(4): 1931 doi: 10.3390/ijms22041931
|
| 31 |
Yu-Shik Hwang, Wesley L. Randle, Robert C. Bielby, Julia M. Polak, Athanasios Mantalaris. Enhanced Derivation of Osteogenic Cells from Murine Embryonic Stem Cells After Treatment with HepG2- Conditioned Medium and Modulation of the Embryoid Body Formation Period: Application to Skeletal Tissue Engineering. Tissue Engineering 2006; 12(6): 1381 doi: 10.1089/ten.2006.12.1381
|
| 32 |
Kai Breuhahn, Peter Schirmacher. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1690-1698 doi: 10.3748/wjg.14.1690
|
| 33 |
Ravinder Kaur, Jatin K. Nagpal, Bibhu R. Das. Polymorphism in IGF-2 as a Surrogate Marker for Predisposition towards Tobacco Chewing-Mediated Oral Cancer. Tumor Biology 2005; 26(3): 147 doi: 10.1159/000086486
|
| 34 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives. World Journal of Gastroenterology 2008; 14(16): 2461-2473 doi: 10.3748/wjg.14.2461
|
| 35 |
Yuanyuan Ji, Zhidong Wang, Zongfang Li, Na Huang, Haiyan Chen, Baohua Li, Bo Hui. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway. Cytokine 2017; 90: 44 doi: 10.1016/j.cyto.2016.10.008
|
| 36 |
Giuseppe Tonini, Vladimir Virzì, Maria Elisabetta Fratto, Bruno Vincenzi, Daniele Santini. Targeted Therapy in Biliary Tract Cancer: 2009 Update. Future Oncology 2009; 5(10): 1675 doi: 10.2217/fon.09.130
|
| 37 |
Weiwei Gui, Yiyi Zhu, Shuiya Sun, Weifen Zhu, Bowen Tan, Hanxin Zhao, Chengxin Shang, Fenping Zheng, Xihua Lin, Hong Li, Wei-Ping Jia. Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver. Journal of Molecular Cell Biology 2021; doi: 10.1093/jmcb/mjab030
|